A Study of the TheraBionic P1 Device in Breast Cancer

Clinical trial NCT07218432 · RECRUITING

Trial details

NCT number: NCT07218432
Sponsor: Barbara Ann Karmanos Cancer Institute
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Cancer Stage I Breast Cancer Stage II Breast Cancer Stage IIIA Hormone Receptor Positive Tumor HER2-negative Breast Cancer

Start date: 2026-10-01
Primary completion: 2027-04-30
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.